Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Crystal Arthritis
•
General Rheumatology
How would you treat tophaceous gout after a course of pegloticase infusions if the patient has contraindications or intolerance to allopurinol, febuxostat, and probenecid?
Related Questions
Would you use febuxostat for an African-American patient with gout and previous cardiovascular events (stroke, MI) who tested positive for HLA-B*5801?
How do you treat nocturnal leg cramps?
In a patient with negative Hep B surface Ag, Hep B surface antibody+, and Hep B core antibody+ serologies, do you initiate antiviral prophylaxis (e.g. entecavir) prior to starting rituximab?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
Is there any value to IgG subclasses in assessing immune deficiency in a patient with normal IgG levels?
Do you reduce the dose of hydroxychloroquine in patients with skin graying if they are not particularly bothered by this side effect?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
Do you use naltrexone in your patients with fibromyalgia?
Can lupus anticoagulant be positive despite a normal aPTT?
